dimarts, 24 de juny del 2014

Cell therapy for early-onset inflammatory bowel disease?




Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital.






By Nancy Fliesler


Inflammatory bowel disease (IBD) is miserable for anyone, but when it strikes a child under age 5, it's much more severe, usually causing bloody diarrhea, wrenching abdominal pain and stunted growth. Early-onset IBD is rare, but on the rise: For reasons unknown, its incidence is increasing by about 5 percent per year in some parts of the world.



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ma8Tyo

Cap comentari:

Publica un comentari a l'entrada